**To the Editor:** We initiated enhanced surveillance for human fascioliasis after a reported increase in livestock cases in the United Kingdom. From January 1, 2008, through January 31, 2009, 11 human cases were confirmed by the reference laboratory for England and Wales, compared with 6 cases during the preceding 10 years. The Scottish reference laboratory detected no human cases during the study period.

Fascioliasis was defined as a positive *Fasciola* immunofluorescent antibody test with a screening titer of 1:32 and either compatible clinical or radiologic features consistent with the disease. We obtained clinical and radiologic information from the referring physician. Clinical features of both acute and chronic infection include fever, upper abdominal pain, malaise, eosinophilia, and impaired liver function; therefore, distinguishing between the 2 phases can be difficult. Fifty percent of chronic infection is subclinical ([@R1]*,*[@R2]). Compatible radiologic features are capsular enhancement with contrast, hypodense nodular areas, and low-density serpiginous lesions ([@R2]). Our analysis comprised 11 cases ([Table](#T1){ref-type="table"}). Two patients were white British, both of whom had recently traveled to sub-Saharan Africa. Cases from the preceding 10 years diagnosed in our laboratory were all in persons with histories of travel to fascioliasis-endemic areas. Therefore, these cases do not provide firm evidence of indigenous zoonotic transmission within England and Wales.

###### Characteristics of human fascioliasis case-patients during enhanced surveillance, United Kingdom, January 1, 2008--January 31, 2009\*

  ---------- ------------ ------------------- -------------------------------- -------------------------------- ------------- ------------------------------------------------- ----------------------------- ------------------------- ------------------------------------------------------------- -------
  Case no.   Age, y/sex   Country of origin   Years since migration            Other travel                     Risk factor   Clinical features                                 Eosinophil count, x10^9^/L)   Abnormal liver function   Hepatic imaging                                               IFAT†
  1          45/F         Yemen               7                                Yemen regularly                  *Khat* use    Abdominal pain                                    8.4                           Yes                       Mixed-density liver lesion (CT)                               1:128
  2          44/M         Somalia             16                               Ethiopia 2007                    *Khat* use    Fever, abdominal pain                             3.4                           Yes                       Serpiginous lesion (MRI)                                      1:64
  3          34/F         Ethiopia            3                                S. Africa regularly              *Khat* use    Fever, abdominal pain                             11.4                          No                        Heterogeneous lesion (USS)                                    1:128
  4          44/F         Somalia             7                                Somalia 2004, Netherlands        *Khat* use    Abdominal pain                                    8.3                           No                        Heterogeneous lesion (USS)                                    1:128
  5          54/F         Somalia             21 (to Netherlands), 4 (to UK)   None                             *Khat* use    Anorexia                                          8.4                           No                        Low-density lesion (CT)                                       1:32
  6          43/M         Somalia             28 (to India), 21 (to UK)        None                             *Khat* use    Fever                                             1.0                           Yes                       Heterogeneous lesion (USS)                                    1:128
  7          28/F         UK                  --                               Uganda 2007--2008                --            Abdominal pain, hepatomegaly                      1.84                          Yes                       Hepatomegaly with large mixed cystic and solid lesion (USS)   1:512
  8          67/M         UK                  --                               Kenya 2008, prior world travel   --            Malaise, abdominal pain                           0.04                          Yes                       Multiple gallstones (MRCP)                                    1:256
  9          38/M         Ethiopia            10                               Ethiopia 2006                    --            Abdominal pain, fever                             18.7                          Yes                       Normal (USS, MRCP)                                            1:128
  10         28/M         Ethiopia            Unknown                          Unknown                          --            Fever, gram- negative sepsis; new HIV diagnosis   \<0.04                        Yes                       Lesion in hepatic vein                                        1:64
  11         47/F         Somalia             16 (to Yemen), 6 (to UK)         Unknown                          *Khat* use    Abdominal pain, fever                             16.8                          Yes                       Low-density lesion (CT)                                       1:256
  ---------- ------------ ------------------- -------------------------------- -------------------------------- ------------- ------------------------------------------------- ----------------------------- ------------------------- ------------------------------------------------------------- -------

\*IFAT, immunofluorescent antibody test; CT, computed tomography; MRI, magnetic resonance imaging; USS, ultrasound scan, MRCP, magnetic resonance cholangiopancreatography. †Titer of IFAT (screening titer 32).

Nine patients originated from Somalia, Ethiopia, or Yemen. Few cases have previously been reported from this area ([@R3]), although Ethiopian migrants have been shown to have an egg positivity of 0.4% on routine screening ([@R4]). Patients 5 and 6 had not returned to Africa for \>20 years, suggesting that they acquired their infection in Europe. Therefore, a risk factor may exist that is specific to this ethnic group within the United Kingdom.

Six cases were diagnosed at 1 hospital. All 6 patients reported current or past use of locally bought *khat*, a leaf chewed for its stimulant properties. It is imported fresh to the United Kingdom from Africa and is an ideal environment for the survival of *Fasciola* cercariae. It is used most commonly by migrants from the Horn of Africa and Yemen and has been reported in association with acute fascioliasis in the United Kingdom ([@R5]). Use of imported khat may explain the apparently higher incidence of fascioliasis in this ethnic group residing in the United Kingdom.

Despite the described parallel rise in human and veterinary fascioliasis, none of these cases provide clear evidence that recent human cases resulted from zoonotic transmission within the United Kingdom. Most cases occurred in migrants from the Horn of Africa and Yemen, some of whom may have acquired *Fasciola* spp. in their country of origin; other cases appear likely to have been acquired in the United Kingdom, possibly due to use of imported *khat*. Physicians need a heightened awareness of fascioliasis when investigating impaired liver function or abnormal abdominal imaging in migrants or travelers from high-risk areas.
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